Form 4 for CELU Celularity Inc

Accepted 2022-07-15 00:00:00 ET · period of report 2022-07-13 · accession 0000899243-22-026190 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-07-15	2022-07-13	CELU	Jones Anne	Chief Business Off	A - Grant	$0.00	+11.5K	27.9K	+70%	$0
D	2022-07-15	2022-07-13	CELU	Jones Anne	Chief Business Off	A - Grant	$0.00	+33.7K	33.7K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-07-13	A	A	11,483	$0.00	27,888	D	—	—	(F1) These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
2	Derivative	Stock Option (Right to Buy)	2022-07-13	A	A	33,670	$0.00	33,670	D	$10.16 · — to 2032-07-13	33,670 Class A Common Stock	(F2) This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date.